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Table. Outcomes by degree of kidney disease
Complications
Moderate kidney disease, % Severe kidney disease, %
OP (n ¼ 2371) EP (n ¼ 1446) P OP (n ¼ 311) EP (n ¼ 185) P
Mortality 1.6 0.7 .01 4.5 0 .003
Worsening renal function 1.1 0.4 .01 4.2 1.1 .05
Cardiac events 2.9 1.2 .001 8.0 2.7 .01
Respiratory events 2.8 1.1 .0004 6.1 1.1 .007
Composite outcome 5.8 2.1 <.0001 14.8 3.8 .0001
EP, Endovascular procedure; OP, open procedure.
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Volume 60, Number 3 Abstracts 815hypertension (89.9% vs 90.4%, P ¼ .61). OPs were associated with higher
mortality rates (1.9% vs 0.6%, P ¼ .0004), postoperative worsening of
renal function (1.4% vs 0.4%, P ¼ .002), cardiac events (3.5% vs 1.4%,
P < .0001), respiratory complications (3.2% vs 1.1%, P < .0001), and
combined outcomes (6.8% vs 2.3%, P < .0001). The Table reports results
for stratiﬁed analyses. Signiﬁcantly worse outcomes with OP vs EP tech-
niques persisted in multivariate logistic regression models adjusted for
group differences.
Conclusions: In patients with moderate or severe kidney disease,
endovascular revascularization is associated with lower mortality and
reduced postoperative complications compared with open revascularization.
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Objectives: Patients with uncomplicated type B aortic dissections
who are managed medically are at risk of aneurysmal degeneration over
time. However, there is hope that improvement in antihypertensive medica-
tions and stricter blood pressure control will halt this process. The goal of
this study was to determine the rate of aneurysmal degeneration in a
contemporary cohort of patients with medically treated type B dissection.
Methods: All patients with acute uncomplicated type B aortic dissec-
tion who were initially managed medically between March 1999 and March
2011 and had at least two separate axial imaging studies were included.
Maximum aortic growth was calculated by comparing the initial imaging
study with the most current scan or imaging obtained just before any
aortic-related intervention. Predictors of aortic aneurysmal degeneration
were determined using Cox proportional hazards models.
Results: A total of 200 patients (61% male) with medically managed
acute type B dissections receiving multiple imaging studies were identiﬁed.
Average age was 63.4 years and 75.5% had a history of hypertension. Mean
follow-up was 5.3 years (range, 0.1-14.7 years). Mean time between initial
and ﬁnal imaging studies was 3.2 years (range, 0.1-12.9 years). At 5 years,
only 51%were free from aortic growth. Fifty-six patients (28%) required oper-
ative intervention (50 open, 6 endovascular repair) for aneurysmal degenera-
tion, and the actuarial 5-year freedom from intervention was 76%. Mean rate
of aneurysmal degeneration was 24.7 mm/y. Excluding early rapid degener-
ation requiring intervention within the ﬁrst 2 weeks (5 patients [2.5%]), the
mean rate of aneurysmal degenerationwas 12.3mm/y for themaximal lumen
diameter, 3.8 mm/y for the true lumen diameter, and 8.6 mm/y for the false
lumen diameter. Only presenting size >3.5 cm was predictive of future
growth (odds ratio, 2.95; 95% conﬁdence interval, 1.64-5.32; P < .001).
Conclusions: Althoughmedical management of uncomplicated acute,
type B aortic dissections remains the standard of care, a signiﬁcant number of
patients will require operative intervention for aneurysmal degeneration at 5
years. An initial aortic diameter >3.5 cm is predictive of future growth.
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Objectives: Previous studies have found an increase in complication rates
after open repair of complex abdominal aortic aneurysms (AAAs) compared
with infrarenal AAAs, with some reporting increased mortality as well. Little is
known about the complication rates of complex fenestrated endovascular aneu-
rysmrepair (FEVAR)comparedwith standard infrarenalEVAR.Thegoalof this
study was to compare complication rates of FEVAR vs EVAR of AAAs.
Methods: The American College of Surgeons National Surgical Qual-
ity Improvement Program database from 2005 to 2012 was queried for
AAAs (International Classiﬁcation of Diseases, 9th edition, 441.4). Patients
were stratiﬁed according to procedure (FEVAR vs EVAR). A bivariate anal-
ysis was done to assess preoperative and intraoperative risk factors for post-
operative 30-day outcomes. Multivariable logistic regression was conducted
to identify independent associations.
Results: A total of 458 patients underwent FEVARand 19,060patients
underwent EVAR for AAA. Patients undergoingFEVARwere older (P¼ .02)
and less likely to have a bleeding disorder (P¼ .046). The groups were other-
wise matched for comorbidities. FEVAR was associated with increased oper-
ative time (182 vs 153 minutes, P < .001) and postoperative length of stay
(3.3 vs 2.8 days, P¼ .03). There was a statistically signiﬁcant increase in post-
operative transfusions (15.3% vs 6.1%, P< .001) and trends toward increased
cardiac complications (2.2% vs 1.3%,P¼ .09) and theneed for dialysis (1.5% vs
0.8%, P ¼ .08) in the FEVAR group. Mortality (2.4% vs 1.5%, P ¼ .12) and
other complication rates were similar. On multivariable analysis, FEVAR
remained independently associated with the need for postoperative transfu-
sions (odds ratio, 2.48; 95% conﬁdence interval, 1.87-3.28; P < .001).
Conclusions: Unlike open repair, FEVAR and EVAR for AAA have
similar outcomes with no difference in mortality. Although FEVAR was
associated with increased postoperative transfusions, this was not associated
with an increased rate of return to the operating room or mortality. Thus,
FEVAR can be performed safely outside of the clinical trial setting with min-
imal increased risks compared with infrarenal EVAR.
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Objectives: This study evaluated the impact of gender on early and
late outcomes of peripheral vascular interventions (PVIs) for intermittent
claudication (IC) and critical limb ischemia (CLI).
Methods: We reviewed 3338 patients (1316 [39%] women) under-
going PVIs for IC (1892 [57%]) or CLI (1446 [43%]) in the Vascular Study>Eastern Vascular Society
yNew England Society for Vascular Surgery
